Intervention
Control Arm
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
13 shownCombining Fasting and Fibre Interventions to Optimise Their Gut Microbiome-mediated Health BenefitsNCT07691736 · 2026-08-31
RECRUITINGA Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung CancerNCT07217301 · 2025-11-26
RECRUITINGBreast Cancer Resiliency Through Exercise Program (B-REP)NCT06100263 · 2024-05-28
RECRUITINGMechanistic Insights to Weight Loss Maintenance Through SGLT2 InhibitorsNCT05885074 · 2025-01-30
WITHDRAWNEffect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLDNCT04861571 · 2023-10-01
ACTIVE_NOT_RECRUITINGPSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate CancerNCT04557501 · 2021-01-06
ACTIVE_NOT_RECRUITINGiSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIVNCT03123731 · 2018-12-01
COMPLETEDImpact of Specialist Led Integrated Care in COPDNCT03482700 · 2017-12-06
UNKNOWNStudy of ProTmune for Allogeneic HCT in Adult Patients With Hematologic MalignanciesNCT02743351 · 2016-12-20
COMPLETEDReaching Better Health Study: A Website to Improve Type 2 Diabetes Self-ManagementNCT02757937 · 2016-05-01
COMPLETEDA Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast CancerNCT02485678 · 2016-02-01
COMPLETEDAutologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour DefectsNCT02302196 · 2015-09-01
COMPLETEDThe Safety and Efficacy of the ReShape Intragastric Balloon in Obese SubjectsNCT01061385 · 2010-02-01
COMPLETEDCommon conditions
Obesity2Acute Graft-versus-host Disease1Acute Lymphoblastic Leukemia1Acute Myeloid Leukemia1Anomaly of Breast1Breast Cancer Female1Cancer of the Breast1Chronic Myelogenous Leukemia1COPD1Diabetes Mellitus, Type 21Dietary Fibre1Early Stage Breast Cancer1Fasting1Gut Microbiome1Hematologic Malignancies1HIV/AIDS1IO-resistant sqNSCLC1Metabolism Changes1Myelodysplastic Syndromes1NAFLD1Overweight , Obesity1Prostate Cancer1Weight Loss1
Leading sponsors
Buchinger Wilhelmi Development & Holding GmbH1Centre hospitalier de l'Université de Montréal (CHUM)1Children's Hospital of Philadelphia1Fate Therapeutics1Heart of England NHS Trust1Kaiser Permanente1Ontario Clinical Oncology Group (OCOG)1ReShape Lifesciences1Takeda1University of Alabama at Birmingham1University of California, San Diego1University of Iowa1University of Michigan Rogel Cancer Center1
Trial status mix
COMPLETED6
RECRUITING3
ACTIVE_NOT_RECRUITING2
UNKNOWN1
WITHDRAWN1
Phase mix
NA8
PHASE22
PHASE32
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.